Recomendaciones en el manejo de la pandemia por coronavirus SARS-CoV-2 (Covid-19) en pacientes con trasplante renal

Zhu, 2020, A novel coronavirus from patients with pneumonia in China, 2019, N Engl J Med., 382, 10.1056/NEJMoa2001017

Coronavirus disease 2019. Disponible en: https://www.who.int/emergencies/diseases/novel-coronavirus-2019

Holshue, 2020, First Case of 2019 Novel Coronavirus in the United States, N Engl J Med., 382, 10.1056/NEJMoa2001191

Ma, 2020, 2019 novel coronavirus disease in hemodialysis (HD) patients: Report from one HD center in Wuhan, China, medRxiv.

Coronavirus disease 2019 (COVID-19). Situation Report 56. Disponible en: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200316-sitrep-56-covid-19.pdf?sfvrsn=9fda7db2_2

Naicker, 2020, The Novel Coronavirus 2019 epidemic and kidneys, Kidney Int., 10.1016/j.kint.2020.03.001

Zhu, 2020, Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression, Am J Transplant., 10.1111/ajt.15869

Kumar, 2003, Severe acute respiratory syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening, Am J Transplant., 3, 977, 10.1034/j.1600-6143.2003.00197.x

Alghamdi, 2015, MERS CoV infection in two renal transplant recipients: Case report, Am J Transplant., 15, 1101, 10.1111/ajt.13085

Michaels, 2020, Coronavirus Disease 2019: implications of emerging infections for transplantation, Am J Transplant., 10.1111/ajt.15832

Action procedure against cases of infection with the new coronavirus (SARS-CoV-2). Disponible en: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/home.htm

Documento técnico. Manejo clínico del COVID-19: tratamiento médico; 19 de marzo de 2020. Disponible en: https://www.semg.es/images/2020/Coronavirus/20200319_Protocolo_manejo_clinico_tto_COVID-19.pdf

Schonder, 2003, Tacrolimus and lopinavir /ritonavir interaction in liver transplantation, Ann Pharmacother., 37, 1793, 10.1345/aph.1D076

Baden, 2020, Covid-19 - the search for effective therapy, N Engl J Med., 10.1056/NEJMe2005477

Cao, 2020, A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19, N Engl J Med., 10.1056/NEJMoa2001282

Ruan, 2020, Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China, Intensive Care Med.

Ko, 2020, Arguments in favor of remdesivir for treating SARS-CoV-2 infections, Int J Antimicrob Agents., 10.1016/j.ijantimicag.2020.105933

Wu, 2020, Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China, JAMA Intern Med., 10.1001/jamainternmed.2020.0994

Xu X. Effective treatment of severe covid-19 patients with tocilizumab. ChinaXiv.

Fowler, 2019, Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: The CITRIS-ALI Randomized Clinical Trial, JAMA., 322, 1261, 10.1001/jama.2019.11825

Gautret, 2020, Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, Int J Antimicrob Agents., 10.1016/j.ijantimicag.2020.105949

HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID-19. Disponible en: https://professional.heart.org/professional/ScienceNews/UCM_505836_HFSAACCAHA-statement-addresses-concerns-re-using-RAAS-antagonists-in-COVID-19.jsp

Lansbury, 2019, Corticosteroids as adjunctive therapy in the treatment of influenza, Cochrane Database Syst Rev., 2

López-Oliva MO, González E, Miranda RJ y Jiménez C. Management of kidney transplant immunosuppression in positive coronavirus infection requiring hospital admission.